Short Interest Update on Becton Dickinson and Company (BDX)

Becton Dickinson and Company (BDX) : Traders are getting increasingly bearish on Becton Dickinson and Company (BDX), as can be seen in the addition of short positions from 2,783,642 on Jul 29, 2016, to 2,912,404 on August 15, 2016. The net change in shorts is 128,762 shares, an increase of 4.6%. 3 days remain before the expiry. The 1.4% of outstanding short positions on the stock compared to its float, shows that traders expect the stock to fall from the current levels. The daily volume of the stock is 1,006,468. The short interest information was released on Wednesday Aug 24th after the market close.

Becton Dickinson and Company (NYSE:BDX): The stock opened at $174.84 on Wednesday but the bulls could not build on the opening and the stock topped out at $175.26 for the day. The stock traded down to $172.91 during the day, due to lack of any buying support eventually closed down at $173.25 with a loss of -0.95% for the day. The stock had closed at $174.91 on the previous day. The total traded volume was 501,837 shares.


In a related news,The officer (Executive Vice President) of Becton Dickinson & Co, Cohen Gary M sold 29,367 shares at $176.81 on August 11, 2016. The Insider selling transaction had a total value worth of $5,192,379. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.

Becton, Dickinson and Company is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry and the general public. The Company operates through two segments: BD Medical and BD Life Sciences. The Companys Life Sciences segment consists of the BD Diagnostics and BD Biosciences segments. The Companys BD Medical segment focuses on providing solutions to reduce the spread of infection, enhance diabetes treatment and advance drug delivery. The Companys BD Diagnostics provides products for the safe collection and transport of diagnostics specimens, as well as instruments and reagent systems. Its BD Biosciences provide diagnostic and research tools to life science researchers, clinical researchers, laboratory professionals and clinicians.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.